advertisement

Topcon

Ophthalmologica 14

Showing records 1 to 14 | Display all abstracts in Ophthalmologica

60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Lemos V
Ophthalmologica 2015; 0:
60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Augustin AJ
Ophthalmologica 2015; 233: 18-26
60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Cabugueira A
Ophthalmologica 2015; 0:
60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Holz FG
Ophthalmologica 2015; 233: 18-26
60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Noronha M
Ophthalmologica 2015; 0:
60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Haritoglou C; Mayer WJ
Ophthalmologica 2015; 233: 18-26
60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Abegão Pinto L
Ophthalmologica 2015; 0:
60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Bopp S
Ophthalmologica 2015; 233: 18-26
60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Reina M
Ophthalmologica 2015; 0:
60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Scheuerle AF
Ophthalmologica 2015; 233: 18-26
60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Branco J
Ophthalmologica 2015; 0:
60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Maier M
Ophthalmologica 2015; 233: 18-26
60665 Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections
Gomes T
Ophthalmologica 2015; 0:
60117 Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion
Sekundo W; Sandner D; Shirlaw A; Hattenbach LO
Ophthalmologica 2015; 233: 18-26

Issue 16-4

Change Issue


advertisement

Oculus